TY - JOUR
T1 - Designing Molecules
T2 - Specific Peptides for Specific Receptors
AU - Hruby, Victor J.
PY - 1989/3
Y1 - 1989/3
N2 - Summary: Peptides are the largest class of mediators of intercellular communication in the central nervous system. These molecules pose special problems in design for potential medical applications because of the high degree of flexibility, lack of high receptor selectivity, and ready biodegra‐dation or clearance. The global and local use of conformational constraints has overcome these difficulties. Structure‐biological activity relationships, molecular modeling, conformational analysis, conformational calculations, and molecular dynamics simulations can all be used to derive suitable lead structures and conformational models. Often, a single, constrained peptide analogue can be designed, which will have many of the desired biological and biophysical properties, and will serve as a template. Peptide analogues with high potency, exquisite receptor selectivity, and biological stability can be obtained. The approach is illustrated by the design of cyclic enkephalin‐ago‐nist analogues with exceptional δ‐opioid‐receptor selectivity, and of constrained somatostatin analogues that have become opioid peptides and possess potent opioid antagonist activities and exceptional selectivity for μ‐opioid receptors.
AB - Summary: Peptides are the largest class of mediators of intercellular communication in the central nervous system. These molecules pose special problems in design for potential medical applications because of the high degree of flexibility, lack of high receptor selectivity, and ready biodegra‐dation or clearance. The global and local use of conformational constraints has overcome these difficulties. Structure‐biological activity relationships, molecular modeling, conformational analysis, conformational calculations, and molecular dynamics simulations can all be used to derive suitable lead structures and conformational models. Often, a single, constrained peptide analogue can be designed, which will have many of the desired biological and biophysical properties, and will serve as a template. Peptide analogues with high potency, exquisite receptor selectivity, and biological stability can be obtained. The approach is illustrated by the design of cyclic enkephalin‐ago‐nist analogues with exceptional δ‐opioid‐receptor selectivity, and of constrained somatostatin analogues that have become opioid peptides and possess potent opioid antagonist activities and exceptional selectivity for μ‐opioid receptors.
KW - Anticonvulsants
KW - Neuropeptides
KW - Peptide synthesis
KW - Protein conformation
UR - http://www.scopus.com/inward/record.url?scp=0024462585&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024462585&partnerID=8YFLogxK
U2 - 10.1111/j.1528-1157.1989.tb05814.x
DO - 10.1111/j.1528-1157.1989.tb05814.x
M3 - Article
C2 - 2570689
AN - SCOPUS:0024462585
SN - 0013-9580
VL - 30
SP - S42-S50
JO - Epilepsia
JF - Epilepsia
ER -